Primary Record
Zoliflodacin
- In stock
- 7,898 g
- Purity
- 98.5 %
- CAS
- 1620458-09-4
Compound Identifiers & Properties
- CAS
- 1620458-09-4
- PubChem CID
- 76685216
- SMILES
- C[C@@H]1CN2[C@H]([C@@H](O1)C)C3(CC4=CC5=C(C(=C42)F)ON=C5N6[C@H](COC6=O)C)C(=O)NC(=O)NC3=O
- Canonical SMILES
- C[C@@H]1CN2c3c(cc4c(N5C(=O)OC[C@@H]5C)noc4c3F)CC3(C(=O)NC(=O)NC3=O)[C@H]2[C@H](C)O1
Names & Synonyms
- Zoliflodacin
- Zoliflodacina
- Zoliflodacine
- zoliflodacinum
- Zoliflodacin [USAN]
- NUZOLVENCE
- Nuzolvence (TN)
- AZD0914
- AZD-0914
- 1620458-09-4
- UNII-FWL2263R77
- ETX0914
- RefChem:905375
- Zoliflodacin(AZD0914)
- Zoliflodacin (USAN/INN)
- ZOLIFLODACIN [INN]
- ETX-0914
- Zoliflodacin(AZD0914)?
- FWL2263R77
- C22H22FN5O7
- ZOLIFLODACIN [WHO-DD]
- AZD 0914 - Bio-X
- DTXSID101028418
- orb1296233
- CHEMBL3544978
- EXT-0914
- SCHEMBL15879500
- GTPL10875
- EXT0914
- BDBM139376
- DTXCID801513987
- GLXC-22385
- AZD 0914
- ETX 0914
- EX-A2620
- MFCD30489455
- ETX0914; AZD0914; Zoliflodacin
- DB12817
- AC-35757
- BA164192
- HY-17647
- MS-29053
- CS-0016917
- NS00073429
- J3.458.071E
- D11726
- US8889671, 5
- A904291
- Q27278240
- B0084-475910
- (2R,4S,4AS)-11-Fluoro-2,4-dimethyl-8-((4S)-4-methyl-2-oxo-1,3-oxazolidin-3-yl)-1,2,4,4a-tetrahydro-2'H,6H-spiro((1,2)-oxazolo(4,5-g)(1,4)oxazino(4,3-a)quinoline-5,5'-pyrimidine)-2',4',6'(1'H,3'H)-trione
- (4'R,6'S,7'S)-17'-fluoro-4',6'-dimethyl-13'-[(4S)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]-5',15'-dioxa-2',14'-diazaspiro[1,5-diazinane-3,8'-tetracyclo[8.7.0.02,7.012,16]heptadecane]-1'(10'),11',13',16'-tetraene-2,4,6-trione
- (4'R,6'S,7'S)-17'-fluoro-4',6'-dimethyl-13'-[(4S)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]spiro[1,3-diazinane-5,8'-5,15-dioxa-2,14-diazatetracyclo[8.7.0.02,7.012,16]heptadeca-1(17),10,12(16),13-tetraene]-2,4,6-trione
- (2R,4S,4aS)-11-Fluoro-1,2,4,4a-tetrahydro-2,4-dimethyl-8-((4S)-4-methyl-2-oxo-3-oxazolidinyl)spiro(isoxazolo(4,5-g)(1,4)oxazino(4,3-a)quinoline-5(6H),5'(2'H)-pyrimidine)-2',4',6'(1'H,3'H)-trione
- (2R,4S,4aS)-11-Fluoro-1,2,4,4a-tetrahydro-2,4-dimethyl-8-[(4S)-4-methyl-2-oxo-3-oxazolidinyl]spiro[isoxazolo[4,5-g][1,4]oxazino[4,3-a]quinoline-5(6H),5'(2'H)-pyrimidine]-2',4',6'(1'H,3'H)-trione
- (2R,4S,4aS)-11-Fluoro-1,2,4,4a-tetrahydro-2,4-dimethyl-8-[(4S)-4-methyl-2-oxo-3-oxazolidinyl]spiro[isoxazolo[4,5-g][1,4]oxazino[4,3-a]quinoline-5(6H),5'(2'H)-pyrimidine]-2',4',6'(1'H,3'H)-trione; AZD 0914; ETX 0914
- (2R,4S,4aS)-11-fluoro-2,4-dimethyl-8-((S)-4-methyl-2-oxooxazolidin-3-yl)-1,2,4,4a-tetrahydro-2'H,6H-spiro[isoxazolo[4,5-g][1,4]oxazino[4,3-a]quinoline-5,5'-pyrimidine]-2',4',6'(1'H,3'H)-trione
- (2R,4S,4AS)-11-fluoro-2,4-dimethyl-8-((S)-4-methyl-2-oxooxazolidin-3-yl)-2,4,4a,6-tetrahydro-1H,1'H-spiro[isoxazolo[4,5-g][1,4]oxazino[4,3-a]quinoline-5,5'-pyrimidine]-2',4',6'(3'H)-trione
- (4'R,6'S,7'S)-17'-fluoro-4',6'-dimethyl-13'-((4S)-4-methyl-2-oxo-1,3-oxazolidin-3-yl)spiro(1,3-diazinane-5,8'-5,15-dioxa-2,14-diazatetracyclo(8.7.0.02,7.012,16)heptadeca-1(17),10,12(16),13-tetraene)-2,4,6-trione
- (4R,6S,7S)-17-fluoro-4,6-dimethyl-13-[(4S)-4-methyl-2-oxo-oxazolidin-3-yl]spiro[5,15-dioxa-2,14-diazatetracyclo[8.7.0.02,7.012,16]heptadeca-1(17),10,12(16),13-tetraene-8,5'-hexahydropyrimidine]-2',4',6'-trione
- (7S,11R,13S)-3-((4S)-2-Oxo-4-methyltetrahydrooxazole-3-yl)-9-fluoro-11,13-dimethyl-8,7-(ethanoxymethano)-7,8,1 ,2 ,3 ,4 -hexahydrospiro[isoxazolo[4,5-g]quinoline-6(5H),5 (6 H)-pyrimidine]-2 ,4 ,6 -trione
- 11-Fluoro-8-[(4S)-4-methyl-2-oxooxazolidine-3-yl]-2beta,4beta-dimethyl-1,2,4,4abeta-tetrahydrospiro[10H-3,10-dioxa-9,11b-diaza-3H-cyclopenta[b]phenanthrene-5(6H),5 (6 H)-pyrimidine]-2 ,4 ,6 (1 H,3 H)-trione
- R8U
- Spiro[isoxazolo[4,5-g][1,4]oxazino[4,3-a]quinoline-5(6H),5'(2'H)-pyrimidine]-2',4',6'(1'H,3'H)-trione, 11-fluoro-1,2,4,4a-tetrahydro-2,4-dimethyl-8-[(4S)-4-methyl-2-oxo-3-oxazolidinyl]-, (2R,4S,4aS)-